Published in Magn Reson Med on October 23, 2013
Full analytical solution of the bloch equation when using a hyperbolic-secant driving function. Magn Reson Med (2016) 0.75
Fast and quiet MRI using a swept radiofrequency. J Magn Reson (2006) 3.56
Magnetic resonance imaging of short T2 components in tissue. Clin Radiol (2003) 2.43
Structural and functional assessment of trabecular and cortical bone by micro magnetic resonance imaging. J Magn Reson Imaging (2007) 2.24
A strategy for sampling on a sphere applied to 3D selective RF pulse design. Magn Reson Med (1994) 2.02
Gapped pulses for frequency-swept MRI. J Magn Reson (2008) 1.91
Prostate cancer bone metastases promote both osteolytic and osteoblastic activity. J Cell Biochem (2004) 1.77
Density of organic matrix of native mineralized bone measured by water- and fat-suppressed proton projection MRI. Magn Reson Med (2003) 1.68
Transformation in mandibular imaging with sweep imaging with fourier transform magnetic resonance imaging. Arch Otolaryngol Head Neck Surg (2011) 1.65
Magnetic resonance imaging with ultrashort TE (UTE) PULSE sequences: technical considerations. J Magn Reson Imaging (2007) 1.63
Quantitative ultrashort echo time (UTE) MRI of human cortical bone: correlation with porosity and biomechanical properties. J Bone Miner Res (2012) 1.53
High-resolution ZTE imaging of human teeth. NMR Biomed (2012) 1.43
Dental magnetic resonance imaging: making the invisible visible. J Endod (2011) 1.41
Ultra-fast imaging using low flip angles and FIDs. Magn Reson Med (1995) 1.37
Fast imaging in liquids and solids with the Back-projection Low Angle ShoT (BLAST) technique. Magn Reson Imaging (1994) 1.28
Effects of formalin fixation and collagen cross-linking on T2 and magnetization transfer in bovine nasal cartilage. Magn Reson Med (2007) 1.27
Selective 3D ultrashort TE imaging: comparison of "dual-echo" acquisition and magnetization preparation for improving short-T 2 contrast. MAGMA (2007) 1.26
Ultra-short echo-time MRI detects changes in bone mineralization and water content in OVX rat bone in response to alendronate treatment. Bone (2010) 1.16
Optimization of RF excitation to maximize signal and T2 contrast of tissues with rapid transverse relaxation. Magn Reson Med (2010) 1.15
MRI of bone metastases: the choice of the sequence. Cancer Imaging (2004) 1.13
Characterization and correction of system delays and eddy currents for MR imaging with ultrashort echo-time and time-varying gradients. Magn Reson Med (2009) 1.13
Direct depiction of bone microstructure using MRI with zero echo time. Bone (2013) 1.11
Accuracy of high-resolution in vivo micro magnetic resonance imaging for measurements of microstructural and mechanical properties of human distal tibial bone. J Bone Miner Res (2010) 0.99
Multipoint mapping for imaging of semi-solid materials. J Magn Reson (2003) 0.92
Cancer interaction with the bone microenvironment: a workshop of the National Institutes of Health Tumor Microenvironment Study Section. Am J Pathol (2006) 0.87
The role of bone-seeking radionuclides in the palliative treatment of patients with painful osteoblastic skeletal metastases. Cancer Control (2012) 0.85
The EZC-prostate model: noninvasive prostate imaging in living mice. Mol Endocrinol (2003) 0.84
Radiofrequency pulses for simultaneous short T2 excitation and long T2 suppression. Magn Reson Med (2010) 0.81
PAIII prostate tumors express prostate specific antigen (PSA) in Lobund-Wistar rats. Can J Vet Res (2009) 0.80
Multimodal μCT/μMR based semiautomated segmentation of rat vertebrae affected by mixed osteolytic/osteoblastic metastases. Med Phys (2012) 0.79
Why do cancers have high aerobic glycolysis? Nat Rev Cancer (2004) 20.60
A microenvironmental model of carcinogenesis. Nat Rev Cancer (2008) 4.40
Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol (2006) 3.98
Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res (2006) 3.90
Fast and quiet MRI using a swept radiofrequency. J Magn Reson (2006) 3.56
Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res (2009) 3.40
9.4T human MRI: preliminary results. Magn Reson Med (2006) 2.98
Adaptive therapy. Cancer Res (2009) 2.81
Pushing spatial and temporal resolution for functional and diffusion MRI in the Human Connectome Project. Neuroimage (2013) 2.68
Radiomics: the process and the challenges. Magn Reson Imaging (2012) 2.65
Acidity generated by the tumor microenvironment drives local invasion. Cancer Res (2013) 2.63
Ultrahigh field magnetic resonance imaging and spectroscopy. Magn Reson Imaging (2003) 2.34
Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia (2005) 2.17
Proton T2 relaxation study of water, N-acetylaspartate, and creatine in human brain using Hahn and Carr-Purcell spin echoes at 4T and 7T. Magn Reson Med (2002) 2.09
Tumor pH and its measurement. J Nucl Med (2010) 2.08
Renal and systemic pH imaging by contrast-enhanced MRI. Magn Reson Med (2003) 2.05
High resolution pH(e) imaging of rat glioma using pH-dependent relaxivity. Magn Reson Med (2006) 1.97
Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy--a pilot study at 4 T. Radiology (2004) 1.95
Glycolysis in cancer: a potential target for therapy. Int J Biochem Cell Biol (2007) 1.94
The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion. Cancer Res (2009) 1.92
Gapped pulses for frequency-swept MRI. J Magn Reson (2008) 1.91
Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background. Cancer Res (2008) 1.88
Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37. Biochemistry (2004) 1.86
Hitting multiple targets with multimeric ligands. Expert Opin Ther Targets (2004) 1.86
Responsive MRI agents for sensing metabolism in vivo. Acc Chem Res (2009) 1.84
In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn Reson Med (2003) 1.76
Exchange-influenced T2rho contrast in human brain images measured with adiabatic radio frequency pulses. Magn Reson Med (2005) 1.70
Imaging pH and metastasis. NMR Biomed (2011) 1.67
Lanthanide-based time-resolved fluorescence of in cyto ligand-receptor interactions. Anal Biochem (2004) 1.66
Transformation in mandibular imaging with sweep imaging with fourier transform magnetic resonance imaging. Arch Otolaryngol Head Neck Surg (2011) 1.65
Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity. Biochem J (2004) 1.65
In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Magn Reson Med (2004) 1.65
T1rho MRI contrast in the human brain: modulation of the longitudinal rotating frame relaxation shutter-speed during an adiabatic RF pulse. J Magn Reson (2006) 1.64
Contributions of cell metabolism and H+ diffusion to the acidic pH of tumors. Neoplasia (2003) 1.63
Stability of FDG-PET Radiomics features: an integrated analysis of test-retest and inter-observer variability. Acta Oncol (2013) 1.62
Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts. Mov Disord (2007) 1.60
Metabolic changes during carcinogenesis: potential impact on invasiveness. J Theor Biol (2006) 1.59
Novel targeting strategy based on multimeric ligands for drug delivery and molecular imaging: homooligomers of alpha-MSH. Bioorg Med Chem Lett (2004) 1.58
Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro. Biochem Pharmacol (2003) 1.57
Quantitative imaging in cancer evolution and ecology. Radiology (2013) 1.55
Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells. Mol Cancer Ther (2005) 1.54
Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors. Neoplasia (2005) 1.54
Transverse relaxation in the rotating frame induced by chemical exchange. J Magn Reson (2004) 1.52
In vivo 1H2O T2+ measurement in the human occipital lobe at 4T and 7T by Carr-Purcell MRI: detection of microscopic susceptibility contrast. Magn Reson Med (2002) 1.52
Lateral phase separation in lipid-coated microbubbles. Langmuir (2006) 1.52
Of cancer and cave fish. Nat Rev Cancer (2011) 1.50
SWIFT detection of SPIO-labeled stem cells grafted in the myocardium. Magn Reson Med (2010) 1.49
Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. Proc Natl Acad Sci U S A (2005) 1.47
Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478. Neoplasia (2005) 1.45
Metabolite quantification and high-field MRS in breast cancer. NMR Biomed (2009) 1.45
Acid treatment of melanoma cells selects for invasive phenotypes. Clin Exp Metastasis (2008) 1.44
Sweat but no gain: inhibiting proliferation of multidrug resistant cancer cells with "ersatzdroges". Int J Cancer (2014) 1.44
In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice. J Neurosci (2005) 1.42
Drug resistance and cellular adaptation to tumor acidic pH microenvironment. Mol Pharm (2011) 1.42
Dental magnetic resonance imaging: making the invisible visible. J Endod (2011) 1.41
Imaging the extracellular pH of tumors by MRI after injection of a single cocktail of T1 and T2 contrast agents. NMR Biomed (2011) 1.40
Determining suitable internal standards for mRNA quantification of increasing cancer progression in human breast cells by real-time reverse transcriptase polymerase chain reaction. Anal Biochem (2005) 1.38
Tumor acidity, ion trapping and chemotherapeutics. II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents. Biochem Pharmacol (2003) 1.38
Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments. Cancer Res (2012) 1.38
Automated Delineation of Lung Tumors from CT Images Using a Single Click Ensemble Segmentation Approach. Pattern Recognit (2013) 1.36
Multiscale modelling of vascular tumour growth in 3D: the roles of domain size and boundary conditions. PLoS One (2011) 1.36
Heterobivalent ligands crosslink multiple cell-surface receptors: the human melanocortin-4 and delta-opioid receptors. Angew Chem Int Ed Engl (2008) 1.36
A physical sciences network characterization of non-tumorigenic and metastatic cells. Sci Rep (2013) 1.33
Quantitative T(1rho) and adiabatic Carr-Purcell T2 magnetic resonance imaging of human occipital lobe at 4 T. Magn Reson Med (2005) 1.32
Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI. Neoplasia (2002) 1.32
Synthesis and evaluation of bivalent NDP-alpha-MSH(7) peptide ligands for binding to the human melanocortin receptor 4 (hMC4R). Bioconjug Chem (2007) 1.31
Eliminating spurious lipid sidebands in 1H MRS of breast lesions. Magn Reson Med (2002) 1.30
Localized 1H NMR spectroscopy in different regions of human brain in vivo at 7 T: T2 relaxation times and concentrations of cerebral metabolites. NMR Biomed (2011) 1.29
Systemic buffers inhibit carcinogenesis in TRAMP mice. J Urol (2012) 1.28
Zoomed functional imaging in the human brain at 7 Tesla with simultaneous high spatial and high temporal resolution. Neuroimage (2002) 1.28
Development of a lanthanide-based assay for detection of receptor-ligand interactions at the delta-opioid receptor. Anal Biochem (2005) 1.25
MRI contrast from relaxation along a fictitious field (RAFF). Magn Reson Med (2010) 1.24
Improved gradient-echo 3D magnetic resonance imaging using pseudo-echoes created by frequency-swept pulses. Magn Reson Med (2006) 1.24
Regulation of the Warburg effect in early-passage breast cancer cells. Neoplasia (2008) 1.23
Thermostability of firefly luciferases affects efficiency of detection by in vivo bioluminescence. Mol Imaging (2004) 1.23
A stimulus-responsive contrast agent for ultrasound molecular imaging. Biomaterials (2007) 1.22
Measurement and correction of respiration-induced B0 variations in breast 1H MRS at 4 Tesla. Magn Reson Med (2004) 1.21
Reduction of metastasis using a non-volatile buffer. Clin Exp Metastasis (2011) 1.21
Enhanced targeting with heterobivalent ligands. Mol Cancer Ther (2009) 1.21
Expanding the use of magnetic resonance in the assessment of tumor response to therapy: workshop report. Cancer Res (2005) 1.21
Evolutionary dynamics of cancer prevention. Nat Rev Cancer (2010) 1.20
Rigid linkers for bioactive peptides. Bioconjug Chem (2006) 1.19
Expression-driven reverse engineering of targeted imaging and therapeutic agents. Expert Opin Ther Targets (2003) 1.19
Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settings. Clin Nucl Med (2013) 1.19
Evolutionary approaches to prolong progression-free survival in breast cancer. Cancer Res (2012) 1.19
Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3 T. Magn Reson Med (2005) 1.17
The thioredoxin-1 inhibitor 1-methylpropyl 2-imidazolyl disulfide (PX-12) decreases vascular permeability in tumor xenografts monitored by dynamic contrast enhanced magnetic resonance imaging. Clin Cancer Res (2005) 1.17
DNA and polylysine adsorption and multilayer construction onto cationic lipid-coated microbubbles. Langmuir (2007) 1.16